Macrophage autophagy in atherosclerosis

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Maiuri, Maria Chiara ^a,b   Grassia, Gianluca ^a,c   Platt, Andrew M ^c   Carnuccio, Rosa ^a   Ialenti, Armando ^a   Maffia, Pasquale ^a,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 [4 [1 (1,4 DIOXASPIRO[4.5]DEC 8 YL) 4 (8 OXA 3 AZABICYCLO[3.2.1]OCT 3 YL) 1H PYRAZOLO[3,4 D]PYRIMIDIN 6 YL]PHENYL] 3 METHYLUREA; 2 MORPHOLINO 8 PHENYLCHROMONE; AMIODARONE; AZD 8055; BAFILOMYCIN A1; CARBAMAZEPINE; EVEROLIMUS; HYDROXYCHLOROQUINE; LITHIUM; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; METFORMIN; NICLOSAMIDE; PERHEXILINE; RAPAMYCIN; ROTTLERIN; TAMOXIFEN; VALPROIC ACID; VERAPAMIL; WORTMANNIN;

ATHEROSCLEROSIS; AUTOPHAGY; CELL ORGANELLE; COMPLEX FORMATION; CYTOPLASM; HUMAN; LYSOSOME; MACROPHAGE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; TUMOR SUPPRESSOR GENE; ANIMAL; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ATHEROSCLEROSIS; AUTOPHAGY; HUMANS; MACROPHAGES;

EID: 84874530407     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/584715     Document Type: Review

References (202)

1. Galkina E., Ley K., Immune and inflammatory mechanisms of atherosclerosis. Annual Review of Immunology 2009 27 165 197 2-s2.0-67650720510 10.1146/annurev.immunol.021908.132620
2. Libby P., Ridker P. M., Hansson G. K., Progress and challenges in translating the biology of atherosclerosis. Nature 2011 473 7347 317 325 2-s2.0-79956319051 10.1038/nature10146
3. Moore K. J., Tabas I., Macrophages in the pathogenesis of atherosclerosis. Cell 2011 145 3 341 355 2-s2.0-79955535643 10.1016/j.cell.2011. 04.005
4. Verheye S., Martinet W., Kockx M. M., Knaapen M. W. M., Salu K., Timmermans J. P., Ellis J. T., Kilpatrick D. L., De Meyer G. R. Y., Selective clearance of macrophages in atherosclerotic plaques by autophagy. Journal of the American College of Cardiology 2007 49 6 706 715 2-s2.0-33846815137 10.1016/j.jacc.2006.09.047 (Pubitemid 46205042)
5. De Meyer I., Martinet W., Schrijvers D. M., Toll-like receptor 7 stimulation by imiquimod induces macrophage autophagy and inflammation in atherosclerotic plaques. Basic Research in Cardiology 2012 107 3 269 10.1007/s00395-012-0269-1
6. Razani B., Feng C., Coleman T., Autophagy links inflammasomes to atherosclerotic progression. Cell Metabolism 2012 15 4 534 544 10.1016/j.cmet.2012.02.011
7. Liao X., Sluimer J. C., Wang Y., Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metabolism 2012 4 4 545 553
8. Ginhoux F., Greter M., Leboeuf M., Nandi S., See P., Gokhan S., Mehler M. F., Conway S. J., Ng L. G., Stanley E. R., Samokhvalov I. M., Merad M., Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010 330 6005 841 845 2-s2.0-78149360132 10.1126/science.1194637
9. Schulz C., Gomez Perdiguero E., Chorro L., A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 2012 336 6077 86 90 10.1126/science.1219179
10. Gautier E. L., Jakubzick C., Randolph G. J., Regulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 10 1412 1418 2-s2.0-70349564487 10.1161/ATVBAHA.108.180505
11. Auffray C., Fogg D., Garfa M., Elain G., Join-Lambert O., Kayal S., Sarnacki S., Cumano A., Lauvau G., Geissmann F., Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007 317 5838 666 670 2-s2.0-34547728312 10.1126/science.1142883 (Pubitemid 47229966)
12. Tushinski R. J., Oliver I. T., Guilbert L. J., Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell 1982 28 1 71 81 2-s2.0-0020078038 (Pubitemid 12223309)
13. Geissmann F., Jung S., Littman D. R., Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003 19 1 71 82 2-s2.0-0037963473 10.1016/S1074-7613(03)00174-2 (Pubitemid 36859902)
14. Ingersoll M. A., Spanbroek R., Lottaz C., Gautier E. L., Frankenberger M., Hoffmann R., Lang R., Haniffa M., Collin M., Tacke F., Habenicht A. J. R., Ziegler-Heitbrock L., Randolph G. J., Comparison of gene expression profiles between human and mouse monocyte subsets (Blood (2010) 115, 3 (e10-e19)). Blood 2010 116 5 857 2-s2.0-77956522849 10.1182/blood-2010-06-290122
15. Serbina N. V., Pamer E. G., Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nature Immunology 2006 7 3 311 317 2-s2.0-33645902493 10.1038/ni1309
16. Ingersoll M. A., Platt A. M., Potteaux A. M., Randolph G. J., Monocyte trafficking in acute and chronic inflammation. Trends in Immunology 2011 32 10 470 477 10.1016/j.it.2011.05.001
17. Gerrity R. G., The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. American Journal of Pathology 1981 103 2 181 190 2-s2.0-0019491124 (Pubitemid 11112973)
18. Swirski F. K., Pittet M. J., Kircher M. F., Aikawa E., Jaffer F. A., Libby P., Weissleder R., Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proceedings of the National Academy of Sciences of the United States of America 2006 103 27 10340 10345 2-s2.0-33745876256 10.1073/pnas.0604260103 (Pubitemid 44051168)
19. Smith J. D., Trogan E., Ginsberg M., Grigaux C., Tian J., Miyata M., Decreased atherosclerosis in mice deficient in both macrophage colony- stimulating factor (op) and apolipoprotein E. Proceedings of the National Academy of Sciences of the United States of America 1995 92 18 8264 8268 2-s2.0-0029079926 10.1073/pnas.92.18.8264
20. Koenen R. R., Weber C., Therapeutic targeting of chemokine interactions in atherosclerosis. Nature Reviews Drug Discovery 2010 9 2 141 153 2-s2.0-75949126309 10.1038/nrd3048
21. Van Wanrooij E. J. A., De Jager S. C. A., Van Es T., De Vos P., Birch H. L., Owen D. A., Watson R. J., Biessen E. A. L., Chapman G. A., Van Berkel T. J. C., Kuiper J., CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 2 251 257 2-s2.0-38549146090 10.1161/ATVBAHA.107.147827 (Pubitemid 351161196)
22. Mestas J., Ley K., Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends in Cardiovascular Medicine 2008 18 6 228 232 2-s2.0-58649100256 10.1016/j.tcm.2008.11.004
23. Combadière C., Potteaux S., Rodero M., Simon T., Pezard A., Esposito B., Merval R., Proudfoot A., Tedgui A., Mallat Z., Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6Chi and Ly6Clo monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 2008 117 13 1649 1657 2-s2.0-41649100060 10.1161/CIRCULATIONAHA.107.745091 (Pubitemid 351482605)
24. Swirski F. K., Libby P., Aikawa E., Alcaide P., Luscinskas F. W., Weissleder R., Pittet M. J., Ly-6Chi monocytes dominate hypercholesterolemia- associated monocytosis and give rise to macrophages in atheromata. Journal of Clinical Investigation 2007 117 1 195 205 2-s2.0-33845970192 10.1172/JCI29950 (Pubitemid 46048466)
25. Potteaux S., Gautier E. L., Hutchison S. B., Van Rooijen N., Rader D. J., Thomas M. J., Sorci-Thomas M. G., Randolph G. J., Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression. Journal of Clinical Investigation 2011 121 5 2025 2036 2-s2.0-79955503060 10.1172/JCI43802
26. Tacke F., Alvarez D., Kaplan T. J., Jakubzick C., Spanbroek R., Llodra J., Garin A., Liu J., Mack M., Van Rooijen N., Lira S. A., Habenicht A. J., Randolph G. J., Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. Journal of Clinical Investigation 2007 117 1 185 194 2-s2.0-33845989083 10.1172/JCI28549 (Pubitemid 46048465)
27. Johnson J. L., Newby A. C., Macrophage heterogeneity in atherosclerotic plaques. Current Opinion in Lipidology 2009 20 5 370 378 2-s2.0-73349092422 10.1097/MOL.0b013e3283309848
28. Podrez E. A., Febbraio M., Sheibani N., Schmitt D., Silverstein R. L., Hajjar D. P., Cohen P. A., Frazier W. A., Hoff H. F., Hazen S. L., Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. Journal of Clinical Investigation 2000 105 8 1095 1108 2-s2.0-0034051080 (Pubitemid 30217694)
29. Suzuki H., Kurihara Y., Takeya M., Kamada N., Kataoka M., Jishage K., Ueda O., Sakaguchi H., Higashi T., Suzuki T., Takashima Y., Kawabe Y., Cynshi O., Wada Y., Honda M., Kurihara H., Aburatani H., Doi T., Matsumoto A., Azuma S., Noda T., Toyoda Y., Itakura H., Yazaki Y., Horiuchi S., Takahashi K., Kruijt J. K., Van Berkel T. J. C., Steinbrecher U. P., Ishibashi S., Maeda N., Gordon S., Kodama T., A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 1997 386 6622 292 296 2-s2.0-0030895048 10.1038/386292a0 (Pubitemid 27142516)
30. Stewart C. R., Stuart L. M., Wilkinson K., Van Gils J. M., Deng J., Halle A., Rayner K. J., Boyer L., Zhong R., Frazier W. A., Lacy-Hulbert A., Khoury J. E., Golenbock D. T., Moore K. J., CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nature Immunology 2010 11 2 155 161 2-s2.0-75649087741 10.1038/ni.1836
31. Berberian P. A., Myers W., Tytell M., Challa V., Bond M. G., Immunohistochemical localization of heat shock protein-70 in normal-appearing and atherosclerotic specimens of human arteries. American Journal of Pathology 1990 136 1 71 80 2-s2.0-0025125876 (Pubitemid 20034954)
32. Yan Z. Q., Hansson G. K., Innate immunity, macrophage activation, and atherosclerosis. Immunological Reviews 2007 219 1 187 203 10.1111/j.1600-065X. 2007.00554.x (Pubitemid 47390007)
33. Duewell P., Kono H., Rayner K. J., Sirois C. M., Vladimer G., Bauernfeind F. G., Abela G. S., Franchi L., Nũez G., Schnurr M., Espevik T., Lien E., Fitzgerald K. A., Rock K. L., Moore K. J., Wright S. D., Hornung V., Latz E., NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010 464 7293 1357 1361 2-s2.0-77951800951 10.1038/nature08938
34. Rajamaki K., Lappalainen J., Oorni K., Valimaki E., Matikainen S., Kovanen P. T., Kari E. K., Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS ONE 2010 5 7 2-s2.0-77955356552 10.1371/journal.pone.0011765 e11765
35. Kleemann R., Zadelaar S., Kooistra T., Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovascular Research 2008 79 3 360 376 2-s2.0-48749110858 10.1093/cvr/cvn120
36. Spanbroek R., Grabner R., Lotzer K., Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proceedings of the National Academy of Sciences of the United States of America 2003 100 3 1238 1243 10.1073/pnas.242716099 (Pubitemid 36183986)
37. Pober J. S., Bevilacqua M. P., Mendrick D. L., Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. Journal of Immunology 1986 136 5 1680 1687 2-s2.0-0022606297 (Pubitemid 16119575)
38. Wuttge D. M., Eriksson P., Sirsjö A., Hansson G. K., Stemme S., Expression of interleukin-15 in mouse and human atherosclerotic lesions. American Journal of Pathology 2001 159 2 417 423 2-s2.0-0034880076 (Pubitemid 32751071)
39. Morrell C. N., Reactive oxygen species: finding the right balance. Circulation Research 2008 103 6 571 572 2-s2.0-53249096016 10.1161/CIRCRESAHA. 108.184325
40. Nguyen T., Brunson D., Crespi C. L., Penman B. W., Wishnok J. S., Tannenbaum S. R., DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proceedings of the National Academy of Sciences of the United States of America 1992 89 7 3030 3034 2-s2.0-0026522884
41. Podrez E. A., Schmitt D., Hoff H. F., Hazen S. L., Myeloperoxidase- generated reactive nitrogen species convert LDL into an atherogenic form in vitro. Journal of Clinical Investigation 1999 103 11 1547 1560 2-s2.0-0032701646
42. Hume D. A., The mononuclear phagocyte system. Current Opinion in Immunology 2006 18 1 49 53 10.1016/j.coi.2005.11.008 (Pubitemid 43049647)
43. Liu J., Sukhova G. K., Sun J. S., Lysosomal cysteine proteases in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 8 1359 1366 10.1161/01.ATV.0000134530.27208.41 (Pubitemid 39056073)
44. Newby A. C., Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 12 2108 2114 2-s2.0-57549112353 10.1161/ATVBAHA.108.173898
45. Febbraio M., Hajjar D. P., Silverstein R. L., CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. Journal of Clinical Investigation 2001 108 6 785 791 2-s2.0-0034833822 10.1172/JCI200114006 (Pubitemid 32880285)
46. Thorp E., Cui D., Schrijvers D. M., Kuriakose G., Tabas I., Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of Apoe-/- mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 8 1421 1428 2-s2.0-52449109523 10.1161/ATVBAHA.108.167197
47. Schrijvers D. M., De Meyer G. R., Kockx M. M., Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 6 1256 1261 10.1161/01.ATV.0000166517. 18801.a7 (Pubitemid 40776618)
48. Böttcher A., Gaipl U. S., Fürnrohr B. G., Herrmann M., Girkontaite I., Kalden J. R., Voll R. E., Involvement of phosphatidylserine, α v β 3, CD14, CD36, and complement C1q in the phagocytosis of primary necrotic lymphocytes by macrophages. Arthritis and Rheumatism 2006 54 3 927 938 2-s2.0-33644924588 10.1002/art.21660
49. Martinet W., Schrijvers D. M., De Meyer G. R., Necrotic cell death in atherosclerosis. Basic Research in Cardiology 2011 106 5 749 760 10.1007/s00395-011-0192-x
50. Martinet W., Schrijvers D. M., De Meyer G. R., Molecular and cellular mechanisms of macrophage survival in atherosclerosis. Basic Research in Cardiology 2012 107 6 297 10.1007/s00395-012-0297-x
51. Yang Z., Klionsky D. J., Mammalian autophagy: core molecular machinery and signaling regulation. Current Opinion in Cell Biology 2010 22 2 124 131 2-s2.0-77951214016 10.1016/j.ceb.2009.11.014
52. Axe E. L., Walker S. A., Manifava M., Chandra P., Roderick H. L., Habermann A., Griffiths G., Ktistakis N. T., Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum. Journal of Cell Biology 2008 182 4 685 701 2-s2.0-50249084987 10.1083/jcb.200803137
53. Hayashi-Nishino M., Fujita N., Noda T., Yamaguchi A., Yoshimori T., Yamamoto A., A subdomain of the endoplasmic reticulum forms a cradle for autophagosome formation. Nature Cell Biology 2009 11 12 1433 1437 2-s2.0-71649087199
54. Hailey D. W., Rambold A. S., Satpute-Krishnan P., Mitra K., Sougrat R., Kim P. K., Lippincott-Schwartz J., Mitochondria supply membranes for autophagosome biogenesis during starvation. Cell 2010 141 4 656 667 2-s2.0-77952495224 10.1016/j.cell.2010.04.009
55. Tooze S. A., Yoshimori T., The origin of the autophagosomal membrane. Nature Cell Biology 2010 12 9 831 835 2-s2.0-77956414236 10.1038/ncb0910-831
56. Ravikumar B., Moreau K., Jahreiss L., Puri C., Rubinsztein D. C., Plasma membrane contributes to the formation of pre-autophagosomal structures. Nature Cell Biology 2010 12 8 747 757 2-s2.0-77955131007 10.1038/ncb2078
57. Yorimitsu T., Klionsky D. J., Autophagy: molecular machinery for self-eating. Cell Death and Differentiation 2005 12 supplement 2 1542 1552 2-s2.0-27644484061 10.1038/sj.cdd.4401765 (Pubitemid 41553991)
58. Kroemer G., Marino G., Levine B., Autophagy and the integrated stress response. Molecular Cell 2010 40 2 280 293 10.1016/j.molcel.2010.09.023
59. Kroemer G., Levine B., Autophagic cell death: the story of a misnomer. Nature Reviews Molecular Cell Biology 2008 9 12 1004 1010 2-s2.0-56749170677 10.1038/nrm2529
60. Levine B., Kroemer G., Autophagy in the pathogenesis of disease. Cell 2008 132 1 27 42 2-s2.0-37649005234 10.1016/j.cell.2007.12.018
61. Levine B., Mizushima N., Virgin H. W., Autophagy in immunity and inflammation. Nature 2011 469 7330 323 335 2-s2.0-78751672975 10.1038/nature09782
62. Nakagawa I., Amano A., Mizushima N., Yamamoto A., Yamaguchi H., Kamimoto T., Nara A., Funao J., Nakata M., Tsuda K., Hamada S., Yoshimori T., Autophagy defends cells against invading group A Streptococcus. Science 2004 306 5698 1037 1040 2-s2.0-8344247016 10.1126/science.1103966 (Pubitemid 39482907)
63. Ogawa M., Yoshimori T., Suzuki T., Sagara H., Mizushima N., Sasakawa C., Escape of intracellular Shigella from autophagy. Science 2005 307 5710 727 731 2-s2.0-13244256806 10.1126/science.1106036 (Pubitemid 40194643)
64. Paludan C., Schmid D., Landthaler M., Vockerodt M., Kube D., Tuschl T., Münz C., Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 2005 307 5709 593 596 2-s2.0-12844275079 10.1126/science.1104904 (Pubitemid 40165684)
65. Sun J., Hartvigsen K., Chou M. Y., Zhang Y., Sukhova G. K., Zhang J., Lopez-Ilasaca M., Diehl C. J., Yakov N., Harats D., George J., Witztum J. L., Libby P., Ploegh H., Shi G. P., Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice. Circulation 2010 122 8 808 820 2-s2.0-77956629151 10.1161/CIRCULATIONAHA.109.891887
66. Levine B., Klionsky D. J., Development by self-digestion: molecular mechanisms and biological functions of autophagy. Developmental Cell 2004 6 4 463 477 2-s2.0-1842583789 10.1016/S1534-5807(04)00099-1 (Pubitemid 38456176)
67. Xie Z., Klionsky D. J., Autophagosome formation: core machinery and adaptations. Nature Cell Biology 2007 9 10 1102 1109 2-s2.0-34848886914 10.1038/ncb1007-1102 (Pubitemid 47500484)
68. Sarbassov D. D., Ali S. M., Sabatini D. M., Growing roles for the mTOR pathway. Current Opinion in Cell Biology 2005 17 6 596 603 2-s2.0-27544500981 10.1016/j.ceb.2005.09.009 (Pubitemid 41540408)
69. Inoki K., Li Y., Zhu T., Wu J., Guan K. L., TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nature Cell Biology 2002 4 9 648 657 2-s2.0-0036713778 10.1038/ncb839 (Pubitemid 34993700)
70. Ruderman N. B., Xu X. J., Nelson L., AMPK and SIRT1: a long-standing partnership? American Journal of Physiology-Endocrinology and Metabolism 2010 298 4 E751 E760 10.1152/ajpendo.00745.2009
71. Inoki K., Ouyang H., Zhu T., Lindvall C., Wang Y., Zhang X., Yang Q., Bennett C., Harada Y., Stankunas K., Wang C. Y., He X., MacDougald O. A., You M., Williams B. O., Guan K. L., TSC2 integrates wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 2006 126 5 955 968 2-s2.0-33748153690 10.1016/j.cell.2006.06.055 (Pubitemid 44310775)
72. Gwinn D. M., Shackelford D. B., Egan D. F., Mihaylova M. M., Mery A., Vasquez D. S., Turk B. E., Shaw R. J., AMPK phosphorylation of raptor mediates a metabolic checkpoint. Molecular Cell 2008 30 2 214 226 2-s2.0-42949139481 10.1016/j.molcel.2008.03.003 (Pubitemid 351626684)
73. Liang C., Feng P., Ku B., Dotan I., Canaani D., Oh B. H., Jung J. U., Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nature Cell Biology 2006 8 7 688 698 2-s2.0-33745751085 10.1038/ncb1426
74. Matsunaga K., Saitoh T., Tabata K., Omori H., Satoh T., Kurotori N., Maejima I., Shirahama-Noda K., Ichimura T., Isobe T., Akira S., Noda T., Yoshimori T., Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nature Cell Biology 2009 11 4 385 396 2-s2.0-64049086758 10.1038/ncb1846
75. Zhong Y., Wang Q. J., Li X., Yan Y., Backer J. M., Chait B. T., Heintz N., Yue Z., Distinct regulation of autophagic activity by Atg14 L and Rubicon associated with Beclin 1-phosphatidylinositol-3-kinase complex. Nature Cell Biology 2009 11 4 468 476 2-s2.0-64049113909 10.1038/ncb1854
76. Itakura E., Kishi C., Inoue K., Mizushima N., Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Molecular Biology of the Cell 2008 19 12 5360 5372 2-s2.0-59249089394 10.1091/mbc.E08-01-0080
77. Sun Q., Fan W., Chen K., Ding X., Chen S., Zhong Q., Identification of Barkor as a mammalian autophagy-specific factor for Beclin 1 and class III phosphatidylinositol 3-kinase. Proceedings of the National Academy of Sciences of the United States of America 2008 105 49 19211 19216 2-s2.0-58049192897 10.1073/pnas.0810452105
78. Fimia G. M., Stoykova A., Romagnoli A., Giunta L., Di Bartolomeo S., Nardacci R., Corazzari M., Fuoco C., Ucar A., Schwartz P., Gruss P., Piacentini M., Chowdhury K., Cecconi F., Ambra1 regulates autophagy and development of the nervous system. Nature 2007 447 7148 1121 1125 2-s2.0-34347344990 10.1038/nature05925 (Pubitemid 47014434)
79. Takahashi Y., Coppola D., Matsushita N., Cualing H. D., Sun M., Sato Y., Liang C., Jung J. U., Cheng J. Q., Mulé J. J., Pledger W. J., Wang H. G., Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nature Cell Biology 2007 9 10 1142 1151 2-s2.0-34848899280 10.1038/ncb1634 (Pubitemid 47500490)
80. Maiuri M. C., Le Toumelin G., Criollo A., Rain J. C., Gautier F., Juin P., Tasdemir E., Pierron G., Troulinaki K., Tavernarakis N., Hickman J. A., Geneste O., Kroemer G., Functional and physical interaction between Bcl-XL and a BH3-like domain in Beclin-1. EMBO Journal 2007 26 10 2527 2539 2-s2.0-34248998801 10.1038/sj.emboj.7601689 (Pubitemid 46788315)
81. Maiuri M. C., Zalckvar E., Kimchi A., Kroemer G., Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nature Reviews Molecular Cell Biology 2007 8 9 741 752 2-s2.0-34548188741 10.1038/nrm2239 (Pubitemid 47312826)
82. Sinha S., Levine B., The autophagy effector Beclin 1: a novel BH3-only protein. Oncogene 2008 27 supplement 1 S137 S148 2-s2.0-68149139456 10.1038/onc.2009.51
83. Levine B., Abrams J., p53: the Janus of autophagy? Nature Cell Biology 2008 10 6 637 639 2-s2.0-44649101436 10.1038/ncb0608-637 (Pubitemid 351772928)
84. Feng Z., Zhang H., Levine A. J., Jin S., The coordinate regulation of the p53 and mTOR pathways in cells. Proceedings of the National Academy of Sciences of the United States of America 2005 102 23 8204 8209 2-s2.0-20444363122 10.1073/pnas.0502857102 (Pubitemid 40800067)
85. Crighton D., Wilkinson S., O'Prey J., DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 2006 126 1 121 134 10.1016/j.cell.2006.05.034 (Pubitemid 44040988)
86. Tasdemir E., Maiuri M. C., Galluzzi L., Regulation of autophagy by cytoplasmic p53. Nature Cell Biology 10 6 676 687 10.1038/ncb1730
87. Baud V., Karin M., Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nature Reviews Drug Discovery 2009 8 1 33 40 10.1038/nrd2781
88. Criollo A., Senovilla L., Authier H., Maiuri M. C., Morselli E., Vitale I., Kepp O., Tasdemir E., Galluzzi L., Shen S., Tailler M., Delahaye N., Tesniere A., De Stefano D., Younes A. B., Harper F., Pierron G., Lavandero S., Zitvogel L., Israel A., Baud V., Kroemer G., The IKK complex contributes to the induction of autophagy. EMBO Journal 2010 29 3 619 631 2-s2.0-76349090912 10.1038/emboj.2009.364
89. Criollo A., Niso-Santano M., Malik S. A., Inhibition of autophagy by TAB2 and TAB3. EMBO Journal 2011 30 24 4908 4920 10.1038/emboj.2011.413
90. Esclatine A., Chaumorcel M., Codogno P., Macroautophagy signaling and regulation. Current Topics in Microbiology and Immunology 2009 335 1 33 70 2-s2.0-75649144802 10.1007/978-3-642-00302-8-2
91. Levine B., Deretic V., Unveiling the roles of autophagy in innate and adaptive immunity. Nature Reviews Immunology 2007 7 10 767 777 2-s2.0-34548700796 10.1038/nri2161 (Pubitemid 47480305)
92. Schmid D., Münz C., Innate and adaptive immunity through autophagy. Immunity 2007 27 1 11 21 2-s2.0-34447629523 10.1016/j.immuni.2007.07.004 (Pubitemid 47089030)
93. Lee H. K., Lund J. M., Ramanathan B., Mizushima N., Iwasaki A., Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 2007 315 5817 1398 1401 2-s2.0-33947134377 10.1126/science.1136880 (Pubitemid 46399546)
94. Sanjuan M. A., Dillon C. P., Tait S. W. G., Moshiach S., Dorsey F., Connell S., Komatsu M., Tanaka K., Cleveland J. L., Withoff S., Green D. R., Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 2007 450 7173 1253 1257 2-s2.0-37549043217 10.1038/nature06421
95. Xu Y., Jagannath C., Liu X. D., Sharafkhaneh A., Kolodziejska K. E., Eissa N. T., Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 2007 27 1 135 144 2-s2.0-34447643958 10.1016/j.immuni.2007.05.022 (Pubitemid 47089027)
96. Delgado M. A., Elmaoued R. A., Davis A. S., Kyei G., Deretic V., Toll-like receptors control autophagy. EMBO Journal 2008 27 7 1110 1121 2-s2.0-41949101594 10.1038/emboj.2008.31 (Pubitemid 351508141)
97. Harris J., De Haro S. A., Master S. S., Keane J., Roberts E. A., Delgado M., Deretic V., T Helper 2 cytokines inhibit autophagic control of intracellular mycobacterium tuberculosis. Immunity 2007 27 3 505 517 2-s2.0-34548700401 10.1016/j.immuni.2007.07.022 (Pubitemid 47418681)
98. Deretic V., Autophagy in infection. Current Opinion in Cell Biology 2010 22 2 252 262 10.1016/j.ceb.2009.12.009
99. Dorn B. R., Dunn W. A. Jr, Progulske-Fox A., Bacterial interactions with the autophagic pathway. Cellular Microbiology 2002 4 1 1 10 2-s2.0-0036158773 10.1046/j.1462-5822.2002.00164.x (Pubitemid 34121273)
100. Kyei G. B., Dinkins C., Davis A. S., Roberts E., Singh S. B., Dong C., Wu L., Kominami E., Ueno T., Yamamoto A., Federico M., Panganiban A., Vergne I., Deretic V., Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. Journal of Cell Biology 2009 186 2 255 268 2-s2.0-67649585835 10.1083/jcb.200903070
101. Gutierrez M. G., Master S. S., Singh S. B., Taylor G. A., Colombo M. I., Deretic V., Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 2004 119 6 753 766 2-s2.0-10944253145 10.1016/j.cell.2004.11.038 (Pubitemid 40017683)
102. Singh S. B., Davis A. S., Taylor G. A., Deretic V., Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 2006 313 5792 1438 1441 2-s2.0-33748506089 10.1126/science.1129577 (Pubitemid 44360272)
103. Saitoh T., Akira S., Regulation of innate immune responses by autophagy-related proteins. Journal of Cell Biology 2010 189 6 925 935 2-s2.0-77953601881 10.1083/jcb.201002021
104. Zhao Z., Fux B., Goodwin M., Dunay I. R., Strong D., Miller B. C., Cadwell K., Delgado M. A., Ponpuak M., Green K. G., Schmidt R. E., Mizushima N., Deretic V., Sibley L. D., Virgin H. W., Autophagosome-independent essential function for the autophagy protein Atg5 in cellular immunity to intracellular pathogens. Cell Host and Microbe 2008 4 5 458 469 2-s2.0-55249109400 10.1016/j.chom.2008.10.003
105. Deretic V., Autophagy in immunity and cell-autonomous defense against intracellular microbes. Immunological Reviews 2011 240 1 92 104 2-s2.0-79951910694 10.1111/j.1600-065X.2010.00995.x
106. Shi C. S., Kehrl J. H., TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-1 to control TLR4-induced Autophagy. Science Signaling 2010 3 123 ra42 2-s2.0-77953858790 10.1126/scisignal.2000751
107. Travassos L. H., Carneiro L. A. M., Ramjeet M., Hussey S., Kim Y. G., Magalhes J. G., Yuan L., Soares F., Chea E., Le Bourhis L., Boneca I. G., Allaoui A., Jones N. L., Nũez G., Girardin S. E., Philpott D. J., Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nature Immunology 2010 11 1 55 62 2-s2.0-73849121209 10.1038/ni.1823
108. Girardin S. E., Travassos L. H., Hervé M., Blanot D., Boneca I. G., Philpott D. J., Sansonetti P. J., Mengin-Lecreulx D., Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. Journal of Biological Chemistry 2003 278 43 41702 41708 2-s2.0-0142180157 10.1074/jbc.M307198200 (Pubitemid 37310428)
109. Inohara N., Koseki T., Lin J., Del Peso L., Lucas P. C., Chen F. F., Ogura Y., Núñez G., An induced proximity model for NF- B activation in the Nod1/RICK and RIP signaling pathways. Journal of Biological Chemistry 2000 275 36 27823 27831 2-s2.0-0034623225 10.1074/jbc.M003415200
110. Abbott D. W., Wilkins A., Asara J. M., Cantley L. C., The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Current Biology 2004 14 24 2217 2227 2-s2.0-11144289688 10.1016/j.cub.2004.12.032 (Pubitemid 40033358)
111. Hugot J. P., Chamaillard M., Zouali H., Lesage S., Cézard J. P., Belaiche J., Almer S., Tysk C., O'morain C. A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J. F., Sahbatou M., Thomas G., Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001 411 6837 599 603 2-s2.0-0035978651 10.1038/35079107 (Pubitemid 32531408)
112. Jounai N., Kobiyama K., Shiina M., Ogata K., Ishii K. J., Takeshita F., NLRP4 negatively regulates autophagic processes through an association with Beclin1. Journal of Immunology 2011 186 3 1646 1655 2-s2.0-79251588741 10.4049/jimmunol.1001654
113. Deretic V., Autophagy as an innate immunity paradigm: expanding the scope and repertoire of pattern recognition receptors. Current Opinion in Immunology 2012 24 1 21 31 10.1016/j.coi.2011.10.006
114. Moscat J., Diaz-Meco M. T., p62 at the crossroads of autophagy, apoptosis, and cancer. Cell 2009 137 6 1001 1004 2-s2.0-66449114033 10.1016/j.cell.2009.05.023
115. Yang J. Q., Liu H., Diaz-Meco M. T., Moscat J., NBR1 is a new PB1 signalling adapter in Th2 differentiation and allergic airway inflammation in vivo. EMBO Journal 2010 29 19 3421 3433 2-s2.0-77957758100 10.1038/emboj.2010. 214
116. Kadandale P., Stender J. D., Glass C. K., Kiger A. A., Conserved role for autophagy in Rho1-mediated cortical remodeling and blood cell recruitment. Proceedings of the National Academy of Sciences of the United States of America 2010 107 23 10502 10507 2-s2.0-77953796877 10.1073/pnas.0914168107
117. Jacquel A., Obba S., Boyer L., Autophagy is required for CSF-1-induced macrophagic differentiation and acquisition of phagocytic functions. Blood 2012 119 19 4527 4531 10.1182/blood-2011-11-392167
118. Polancec D. S., Munic Kos V., Banjanac M., Azithromycin drives in vitro GM-CSF/IL-4-induced differentiation of human blood monocytes toward dendritic-like cells with regulatory properties. Journal of Leukocyte Biology 2012 91 2 229 243 10.1189/jlb.1210655
119. Ponpuak M., Davis A. S., Roberts E. A., Delgado M. A., Dinkins C., Zhao Z., Virgin H. W., Kyei G. B., Johansen T., Vergne I., Deretic V., Delivery of cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique antimicrobial properties. Immunity 2010 32 3 329 341 2-s2.0-77949997805 10.1016/j.immuni.2010.02.009
120. Yuk J. M., Shin D. M., Lee H. M., Yang C. S., Jin H. S., Kim K. K., Lee Z. W., Lee S. H., Kim J. M., Jo E. K., Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host and Microbe 2009 6 3 231 243 2-s2.0-69949184887 10.1016/j.chom.2009.08.004
121. Campbell G. R., Spector S. A., Hormonally active vitamin D3 (1 α25-dihydroxycholecalciferol) triggers autophagy in human macrophages that inhibits HIV-1 infection. Journal of Biological Chemistry 2011 286 21 18890 18902 2-s2.0-79956296127 10.1074/jbc.M110.206110
122. Tang D., Kang R., Livesey K. M., Cheh C. W., Farkas A., Loughran P., Hoppe G., Bianchi M. E., Tracey K. J., Zeh H. J., Lotze M. T., Endogenous HMGB1 regulates autophagy. Journal of Cell Biology 2010 190 5 881 892 2-s2.0-77956386515 10.1083/jcb.200911078
123. Eidi H., Joubert O., Némos C., Drug delivery by polymeric nanoparticles induces autophagy in macrophages. International Journal of Pharmaceutics 2012 422 1-2 495 503 10.1016/j.ijpharm.2011.11.020
124. Virgin H. W., Levine B., Autophagy genes in immunity. Nature Immunology 2009 10 5 461 470 10.1038/ni.1726
125. Deretic V., Levine B., Autophagy, immunity, and microbial adaptations. Cell Host and Microbe 2009 5 6 527 549 2-s2.0-67649607465 10.1016/j.chom.2009. 05.016
126. Saitoh T., Fujita N., Jang M. H., Uematsu S., Yang B. G., Satoh T., Omori H., Noda T., Yamamoto N., Komatsu M., Tanaka K., Kawai T., Tsujimura T., Takeuchi O., Yoshimori T., Akira S., Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1 β production. Nature 2008 456 7219 264 268 2-s2.0-56249090667 10.1038/nature07383
127. Tal M. C., Sasai M., Lee H. K., Yordy B., Shadel G. S., Iwasaki A., Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proceedings of the National Academy of Sciences of the United States of America 2009 106 8 2774 2775 2-s2.0-62449110463 10.1073/pnas. 0S07694106
128. Nakahira K., Haspel J. A., Rathinam V. A. K., Lee S. J., Dolinay T., Lam H. C., Englert J. A., Rabinovitch M., Cernadas M., Kim H. P., Fitzgerald K. A., Ryter S. W., Choi A. M. K., Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nature Immunology 2011 12 3 222 230 2-s2.0-79951642032 10.1038/ni.1980
129. Zhou R., Yazdi A. S., Menu P., Tschopp J., A role for mitochondria in NLRP3 inflammasome activation. Nature 2011 469 7329 221 226 2-s2.0-78651393239 10.1038/nature09663
130. Mihalache C. C., Simon H. U., Autophgy regulation in macrophages and neutrophils. Experimental Cell Research 2012 318 11 1187 1192 10.1016/j.yexcr.2011.12.021
131. Petrovski G., Zahuczky G., Katona K., Vereb G., Martinet W., Nemes Z., Bursch W., Fésüs L., Clearance of dying autophagic cells of different origin by professional and non-professional phagocytes. Cell Death and Differentiation 2007 14 6 1117 1128 2-s2.0-34249011511 10.1038/sj.cdd.4402112 (Pubitemid 46785103)
132. Qu X., Zou Z., Sun Q., Luby-Phelps K., Cheng P., Hogan R. N., Gilpin C., Levine B., Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell 2007 128 5 931 946 2-s2.0-33847404337 10.1016/j.cell.2006.12.044 (Pubitemid 46341412)
133. Martinez J., Almendinger J., Oberst A., Microtubule-associated protein 1 light chain 3 alpha (LC3)-associated phagocytosis is required for the efficient clearance of dead cells. Proceedings of the National Academy of Sciences of the United States of America 2011 108 42 17396 17401 10.1073/pnas.1113421108
134. Fesus L., Demény M. A., Petrovski G., Autophagy shapes inflammation. Antioxidants and Redox Signaling 2011 14 11 2233 2243 2-s2.0-79956131536 10.1089/ars.2010.3485
135. Kockx M. M., De Meyer G. R. Y., Buyssens N., Knaapen M. W. M., Bult H., Herman A. G., Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal. Circulation Research 1998 83 4 378 387 2-s2.0-0032563650 (Pubitemid 28389967)
136. Martinet W., De Meyer G. R. Y., Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential. Circulation Research 2009 104 3 304 317 2-s2.0-61949233502 10.1161/CIRCRESAHA.108.188318
137. Jia G., Cheng G., Gangahar D. M., Agrawal D. K., Insulin-like growth factor-1 and TNF- α regulate autophagy through c-jun N-terminal kinase and Akt pathways in human atherosclerotic vascular smooth cells. Immunology and Cell Biology 2006 84 5 448 454 2-s2.0-33747863220 10.1111/j.1440-1711.2006. 01454.x (Pubitemid 44286038)
138. Scherz-Shouval R., Elazar Z., Regulation of autophagy by ROS: physiology and pathology. Trends in Biochemical Sciences 2011 36 1 30 38 2-s2.0-78650890352 10.1016/j.tibs.2010.07.007
139. Nowicki M., Zabirnyk O., Duerrschmidt N., Borlak J., Spanel-Borowski K., No upregulation of lectin-like oxidized low-density lipoprotein receptor-1 in serum-deprived EA.hy926 endothelial cells under oxLDL exposure, but increase in autophagy. European Journal of Cell Biology 2007 86 10 605 616 2-s2.0-34548604527 10.1016/j.ejcb.2007.06.006 (Pubitemid 47408713)
140. Muller M., Salvayre R., Nègre-Salvayre A., Vindis C., Oxidized LDLs trigger endoplasmic reticulum stress and autophagy: prevention by HDLs. Autophagy 2011 7 5 541 543 2-s2.0-79955697957 10.4161/auto.7.5.15003
141. Zheng Y. H., Tian C., Meng Y., Osteopontin stimulates autophagy via integrin/CD44 and p38 MAPK signaling pathways in vascular smooth muscle cells. Journal of Cellular Physiology 2012 227 1 127 135 10.1002/jcp.22709
142. Hu P., Lai D., Lu P., Gao J., He H., ERK and Akt signaling pathways are involved in advanced glycation end product-induced autophagy in rat vascular smooth muscle cells. International Journal of Molecular Medicine 2012 29 4 613 618
143. Martinet W., De Bie M., Schrijvers D. M., De Meyer G. R. Y., Herman A. G., Kockx M. M., 7-Ketocholesterol induces protein ubiquitination, myelin figure formation, and light chain 3 processing in vascular smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 12 2296 2301 2-s2.0-10644244534 10.1161/01.ATV.0000146266.65820.a1 (Pubitemid 39658032)
144. Sluimer J. C., Gasc J. M., van Wanroij J. L., Kisters N., Groeneweg M., Sollewijn Gelpke M. D., Cleutjens J. P., van den Akker L. H., Corvol P., Wouters B. G., Daemen M. J., Bijnens A. P. J., Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis. Journal of the American College of Cardiology 2008 51 13 1258 1265 2-s2.0-40849086607 10.1016/j.jacc.2007.12.025 (Pubitemid 351400903)
145. Martinet W., De Meyer G. R. Y., Selective depletion of macrophages in atherosclerotic plaques: myth, hype, or reality? Circulation Research 2007 100 6 751 753 2-s2.0-34147099503 10.1161/01.RES.0000263397.14481.96 (Pubitemid 46555676)
146. Wang Q., Zhang M., Liang B., Activation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2. PLoS One 2011 6 9 25436 10.1371/journal.pone.0025436
147. LaRocca T. J., Henson G. D., Thorburn A., Translational evidence that impaired autophagy contributes to arterial ageing. Journal of Physiology 2012 590 14 3305 3316 10.1113/jphysiol.2012.229690
148. Kiffin R., Bandyopadhyay U., Cuervo A. M., Oxidative stress and autophagy. Antioxidants and Redox Signaling 2006 8 1-2 152 162 2-s2.0-33644643603 10.1089/ars.2006.8.152 (Pubitemid 43324542)
149. Martinet W., Schrijvers D. M., Timmermans J. P., Bult H., Interactions between cell death induced by statins and 7-ketocholesterol in rabbit aorta smooth muscle cells. British Journal of Pharmacology 2008 154 6 1236 1246 2-s2.0-47249152694 10.1038/bjp.2008.181 (Pubitemid 351992056)
150. Qin L., Wang Z., Tao L., Wang Y., ER stress negatively regulates AKT/TSC/mTOR pathway to enhance autophagy. Autophagy 2010 6 2 239 247 2-s2.0-77953506788 10.4161/auto.6.2.11062
151. Schrijvers D. M., De Meyer G. R., Martinet W., Autophagy in atherosclerosis: a potential drug target for plaque stabilization. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 12 2787 2791 10.1161/ATVBAHA.111.224899
152. Salabei J. K., Balakumaran A., Frey J. C., Verapamil stereoisomers induce antiproliferative effects in vascular smooth muscle cells via autophagy. Toxicology and Applied Pharmacology 2012 262 3 265 272 10.1016/j.taap.2012.04. 036
153. Döring Y., Manthey H. D., Drechsler M., Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis. Circulation 2012 125 13 1673 1683 10.1161/CIRCULATIONAHA.111.046755
154. MacRitchie N., Grassia G., Sabir S. R., Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2012 32 11 2569 2579 10.1161/ATVBAHA.112.251314
155. Grassia G., MacRitchie N., Platt A. M., Plasmacytoid dendritic cells: biomarkers or potential therapeutic targets in atherosclerosis? Pharmacology & Therapeutics 2012 10.1016/j.pharmthera.2012.10.001
156. Bjorkoy G., Lamark T., Pankiv S., Øvervatn A., Brech A., Johansen T., Chapter 12 monitoring autophagic degradation of p62/SQSTM1. Methods in Enzymology 2009 451 C 181 197 2-s2.0-59249105964 10.1016/S0076-6879(08)03612-4
157. Singh R., Kaushik S., Wang Y., Autophagy regulates lipid metabolism. Nature 2009 458 1131 1135 10.1038/nature07976
158. Singh R., Cuervo A. M., Lipophagy: connecting autophagy and lipid metabolism. International Journal of Cell Biology 2012 2012 12 282041 10.1155/2012/282041
159. Liu K., Czaja M. J., Regulation of lipid stores and metabolism by lipophagy. Cell Death and Differentiation 2013 20 3 11 10.1038/cdd.2012.63
160. Ouimet M., Franklin V., Mak E., Liao X., Tabas I., Marcel Y. L., Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase. Cell Metabolism 2011 13 6 655 667 2-s2.0-79958030075 10.1016/j.cmet.2011.03.023
161. Le Guezennec X., Brichkina A., Huang Y. F., Wip1-dependent regulation of autophagy, obesity, and atherosclerosis. Cell Metabolism 2012 16 1 68 80 10.1016/j.cmet.2012.06.003
162. Fleming A., Noda T., Yoshimori T., Rubinsztein D. C., Chemical modulators of autophagy as biological probes and potential therapeutics. Nature Chemical Biology 2011 7 1 9 17 2-s2.0-78650448754 10.1038/nchembio.500
163. Bischoff P., Jossett E., Dumont F. J., Novel pharmacological modulators of autophagy and therapeutic prospects. Expert Opinion on Therapeutic Patents 2012 22 9 1053 1079 10.1517/13543776.2012.715148
164. Ravikumar B., Vacher C., Berger Z., Davies J. E., Luo S., Oroz L. G., Scaravilli F., Easton D. F., Duden R., O'Kane C. J., Rubinsztein D. C., Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nature Genetics 2004 36 6 585 595 2-s2.0-2642586352 10.1038/ng1362 (Pubitemid 38715985)
165. Berger Z., Ravikumar B., Menzies F. M., Rapamycin alleviates toxicity of different aggregate-prone proteins. Human Molecular Genetics 2006 15 3 433 442 (Pubitemid 43159895)
166. Ravikumar B., Rubinsztein D. C., Role of autophagy in the clearance of mutant huntingtin: a step towards therapy? Molecular Aspects of Medicine 2006 27 5-6 520 527 2-s2.0-33749040671 10.1016/j.mam.2006.08.008 (Pubitemid 44466658)
167. Sarkar S., Perlstein E. O., Imarisio S., Pineau S., Cordenier A., Maglathlin R. L., Webster J. A., Lewis T. A., O'Kane C. J., Schreiber S. L., Rubinsztein D. C., Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nature Chemical Biology 2007 3 6 331 338 2-s2.0-34248994604 10.1038/nchembio883 (Pubitemid 46789270)
168. Sarkar S., Davies J. E., Huang Z., Tunnacliffe A., Rubinsztein D. C., Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and α -synuclein. Journal of Biological Chemistry 2007 282 8 5641 5652 2-s2.0-34247161367 10.1074/jbc.M609532200 (Pubitemid 47093730)
169. Hay N., Sonenberg N., Upstream and downstream of mTOR. Genes and Development 2004 18 16 1926 1945 2-s2.0-4043171462 10.1101/gad.1212704 (Pubitemid 39071573)
170. O'Reilly K. E., Rojo F., She Q. B., mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Research 2006 66 3 1500 1508 10.1158/0008-5472.CAN-05-2925 (Pubitemid 43259931)
171. Yu K., Shi C., Toral-Barza L., Lucas J., Shor B., Kim J. E., Zhang W. G., Mahoney R., Gaydos C., Tardio L., Kim S. K., Conant R., Curran K., Kaplan J., Verheijen J., Ayral-Kaloustian S., Mansour T. S., Abraham R. T., Zask A., Gibbons J. J., Beyond rapalog therapy: preclinical pharmacology and antitumor activity of WYE-125132, an ATP-competitive and specific inhibitor of mTORC1 and mTORC2. Cancer Research 2010 70 2 621 631 2-s2.0-76549107351 10.1158/0008-5472.CAN-09-2340
172. Chresta C. M., Davies B. R., Hickson I., AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. Cancer Research 2010 70 1 288 298 10.1158/0008-5472.CAN-09-1751
173. Feldman M. E., Apsel B., Uotila A., Loewith R., Knight Z. A., Ruggero D., Shokat K. M., Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS biology 2009 7 2 e38 2-s2.0-65249156511 10.1371/journal.pbio.1000038
174. Thoreen C. C., Kang S. A., Chang J. W., Liu Q., Zhang J., Gao Y., Reichling L. J., Sim T., Sabatini D. M., Gray N. S., An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. Journal of Biological Chemistry 2009 284 12 8023 8032 2-s2.0-65549145048 10.1074/jbc.M900301200
175. Balgi A. D., Fonseca B. D., Donohue E., Tsang T. C. F., Lajoie P., Proud C. G., Nabi I. R., Roberge M., Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling. PLoS ONE 2009 4 9 2-s2.0-70349616273 10.1371/journal.pone.0007124 e7124
176. Williams R. S. B., Cheng L., Mudge A. W., Harwood A. J., A common mechanism of action for three mood-stabilizing drugs. Nature 2002 417 6886 292 295 2-s2.0-0037118050 10.1038/417292a (Pubitemid 34534711)
177. Sarkar S., Floto R. A., Berger Z., Imarisio S., Cordenier A., Pasco M., Cook L. J., Rubinsztein D. C., Lithium induces autophagy by inhibiting inositol monophosphatase. Journal of Cell Biology 2005 170 7 1101 1111 2-s2.0-25444483066 10.1083/jcb.200504035 (Pubitemid 41362642)
178. Furuya N., Liang X. H., Levine B., Klionsky D. J., Autophagy and cancer. Autophagy 2004 Georgetown, Tex, USA Landes Bioscience 241 255
179. Dowling R. J. O., Zakikhani M., Fantus I. G., Pollak M., Sonenberg N., Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Research 2007 67 22 10804 10812 2-s2.0-36348950449 10.1158/0008-5472.CAN-07-2310 (Pubitemid 350145909)
180. Sahra I. B., Laurent K., Loubat A., Giorgetti-Peraldi S., Colosetti P., Auberger P., Tanti J. F., Le Marchand-Brustel Y., Bost F., The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. Oncogene 2008 27 25 3576 3586 2-s2.0-44849099894 10.1038/sj.onc.1211024 (Pubitemid 351793803)
181. Buzzai M., Jones R. G., Amaravadi R. K., Lum J. J., DeBerardinis R. J., Zhao F., Viollet B., Thompson C. B., Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Research 2007 67 14 6745 6752 2-s2.0-34547114031 10.1158/0008-5472.CAN-06-4447 (Pubitemid 47105521)
182. Floto R. A., Sarkar S., Perlstein E. O., Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington's disease models and enhance killing of mycobacteria by macrophages. Autophagy 2007 3 6 620 622 (Pubitemid 350060063)
183. Yang Z. J., Chee C. E., Huang S., Sinicrope F. A., Autophagy modulation for cancer therapy. Cancer Biology and Therapy 2011 11 2 169 176 2-s2.0-78751550257 10.4161/cbt.11.2.14663
184. Ryter S. W., Lee S. J., Smith A., Choi A. M., Autophagy in vascular disease. Proceedings of the American Thoracic Society 2010 7 1 40 47 10.1513/pats.200909-100JS
185. Khan S. A., Salloum F., Das A., Xi L., Vetrovec G. W., Kukreja R. C., Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes. Journal of Molecular and Cellular Cardiology 2006 41 2 256 264 2-s2.0-33746090919 10.1016/j.yjmcc.2006. 04.014 (Pubitemid 44080210)
186. Loos B., Engelbrecht A. M., Cell death: a dynamic response concept. Autophagy 2009 5 5 590 603 2-s2.0-67650261911 10.4161/auto.5.5.8479
187. Loos B., Genade S., Ellis B., Lochner A., Engelbrecht A. M., At the core of survival: autophagy delays the onset of both apoptotic and necrotic cell death in a model of ischemic cell injury. Experimental Cell Research 2011 317 10 1437 1453 2-s2.0-79955963895 10.1016/j.yexcr.2011.03.011
188. Nakai A., Yamaguchi O., Takeda T., Higuchi Y., Hikoso S., Taniike M., Omiya S., Mizote I., Matsumura Y., Asahi M., Nishida K., Hori M., Mizushima N., Otsu K., The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nature Medicine 2007 13 5 619 624 2-s2.0-34249714158 10.1038/nm1574 (Pubitemid 46828485)
189. Martinet W., De Meyer I., Verheye S., Drug-induced macrophage autophagy in atherosclerosis: for better or worse? Basic Research in Cardiology 2013 108 1 321 10.1007/s00395-012-0321-1
190. Castro C., Campistol J. M., Sancho D., Sánchez-Madrid F., Casals E., Andrés V., Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27Kip1-independent pathway. Atherosclerosis 2004 172 1 31 38 2-s2.0-0347985757 10.1016/j. atherosclerosis.2003.09.003 (Pubitemid 38058598)
191. Mueller M. A., Beutner F., Teupser D., Ceglarek U., Thiery J., Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/- mice despite severe hypercholesterolemia. Atherosclerosis 2008 198 1 39 48 2-s2.0-40949111498 10.1016/j.atherosclerosis.2007.09.019 (Pubitemid 351406366)
192. Pakala R., Stabile E., Jang G. J., Clavijo L., Waksman R., Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice: inhibitory effect on monocyte chemotaxis. Journal of Cardiovascular Pharmacology 2005 46 4 481 486 2-s2.0-26044448312 10.1097/01.fjc.0000177985. 14305.15 (Pubitemid 41407577)
193. Zhao L., Ding T., Cyrus T., Cheng Y., Tian H., Ma M., Falotico R., Praticò D., Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor. British Journal of Pharmacology 2009 156 5 774 785 2-s2.0-66949167065 10.1111/j.1476-5381.2008.00080.x
194. Guo Z., Mitchell-Raymundo F., Yang H., Ikeno Y., Nelson J., Diaz V., Richardson A., Reddick R., Dietary restriction reduces atherosclerosis and oxidative stress in the aorta of apolipoprotein E-deficient mice. Mechanisms of Ageing and Development 2002 123 8 1121 1131 2-s2.0-0037198056 10.1016/S0047-6374(02)00008-8 (Pubitemid 34603096)
195. Maffia P., Zinselmeyer B. H., Ialenti A., Kennedy S., Baker A. H., McInnes I. B., Brewer J. M., Garside P., Multiphoton microscopy for 3-dimensional imaging of lymphocyte recruitment into apolipoprotein-E-deficient mouse carotid artery. Circulation 2007 115 11 e326 e328 2-s2.0-34147158877 10.1161/CIRCULATIONAHA.106.658492 (Pubitemid 46648386)
196. Galkina E., Kadl A., Sanders J., Varughese D., Sarembock I. J., Ley K., Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. Journal of Experimental Medicine 2006 203 5 1273 1282 2-s2.0-33646692002 10.1084/jem.20052205 (Pubitemid 43736596)
197. Koltsova E. K., Garcia Z., Chodaczek G., Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis. Journal of Clinical Investigation 2012 122 9 3114 3126
198. Ireland J. M., Unanue E. R., Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells. Journal of Experimental Medicine 2011 208 13 2625 2632 10.1084/jem.20110640
199. McLeod I. X., Jia W., He Y. W., The contribution of autophagy to lymphocyte survival and homeostasis. Immunological Reviews 2012 249 1 195 204 10.1111/j.1600-065X.2012.01143.x
200. Paul S., Schaefer B. C., Selective autophagy regulates T-cell activation. Autophagy 2012 8 11 1690 1692 10.1016/j.pharmthera.2012.10.001
201. Morris S., Swanson M. S., Lieberman A., Autophagy-mediated dendritic cell activation is essential for innate cytokine production and APC function with respiratory syncytial virus responses. Journal of Immunology 2011 187 8 3953 3961 10.4049/jimmunol.1100524
202. Nakano H., Ushio H., An unexpected role for autophagy in degranulation of mast cells. Autophagy 2011 7 6 657 659 2-s2.0-79957881710 10.4161/auto.7.6. 15384